UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

The New England journal of medicine, 2010-04, Vol.362 (14), p.1273-1281

2010

Link zum Volltext

Verfügbarkeit prüfen

Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity

Thrombosis and haemostasis, 2019-09, Vol.119 (9), p.1419

2019

Link zum Volltext

Verfügbarkeit prüfen

Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities

Scientific reports, 2020-12, Vol.10 (1), p.20908-20908, Article 20908

2020

Link zum Volltext

Verfügbarkeit prüfen

Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial

Palliative medicine, 2019-05, Vol.33 (5), p.510-517

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolism (a qualitative study)

PloS one, 2022-10, Vol.17 (10), p.e0276754-e0276754

2022

Link zum Volltext

Verfügbarkeit prüfen

Deficient DNA mismatch repair and persistence of SARS-CoV-2 RNA shedding: a case report of hereditary nonpolyposis colorectal cancer with COVID-19 infection

BMC infectious diseases, 2021-08, Vol.21 (1), p.1-854, Article 854

2021

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

Clinical cancer research, 2009-09, Vol.15 (17), p.5591-5598

2009

Link zum Volltext

Verfügbarkeit prüfen

Latest advances in preventing thromboembolic disease in the ambulatory oncology patient

Thrombosis research, 2020-07, Vol.191, p.S91-S98

Maraveyas, Anthony

2020

Link zum Volltext

Verfügbarkeit prüfen

Low molecular weight heparin and direct oral anticoagulants influence tumour formation, growth, invasion and vascularisation by separate mechanisms

Scientific reports, 2019-04, Vol.9 (1), p.6272-6272, Article 6272

2019

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of tissue factor in endothelial cells promotes cellular apoptosis through over-activation of Src1 and involves β1-integrin signalling

Apoptosis (London), 2020-02, Vol.25 (1-2), p.29-41

2020

Link zum Volltext

Verfügbarkeit prüfen

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

The Lancet (British edition), 2007-07, Vol.370 (9582), p.143-152

2007

Link zum Volltext

Verfügbarkeit prüfen

Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity

Thrombosis and haemostasis, 2013-11, Vol.110 (5), p.966

2013

Link zum Volltext

Verfügbarkeit prüfen

The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients

Thrombosis journal, 2017-09, Vol.15 (1), p.25-25, Article 25

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis

Palliative Medicine, 2018-05, Vol.32 (5), p.1010-1020

2018

Link zum Volltext

Verfügbarkeit prüfen

Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles

Biochimica et biophysica acta. Molecular cell research, 2018-01, Vol.1865 (1), p.12-24

2018

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation

Thrombosis and haemostasis, 2015, Vol.114 (2), p.364

2015

Link zum Volltext

Verfügbarkeit prüfen

Chemoradiation in Pancreatic Adenocarcinoma: A Literature Review

The oncologist (Dayton, Ohio), 2010-03, Vol.15 (3), p.259-269

2010

Link zum Volltext

Verfügbarkeit prüfen

De-Palmitoylation of Tissue Factor Regulates Its Activity, Phosphorylation and Cellular Functions

Cancers, 2021-07, Vol.13 (15), p.3837

2021

Link zum Volltext

Verfügbarkeit prüfen

Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study

Thrombosis journal, 2020-05, Vol.18 (1), p.9-9, Article 9

2020

Link zum Volltext

Verfügbarkeit prüfen

Factor VIIa Regulates the Level of Cell-Surface Tissue Factor through Separate but Cooperative Mechanisms

Cancers, 2021-07, Vol.13 (15), p.3718

2021

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series

BMC sports science, medicine & rehabilitation, 2023-09, Vol.15 (1), p.116-116, Article 116

2023

Link zum Volltext

Verfügbarkeit prüfen

COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

Thrombosis journal, 2018-09, Vol.16 (1), p.21-21, Article 21

2018

Link zum Volltext

Verfügbarkeit prüfen

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials

Journal of clinical medicine, 2022-10, Vol.11 (20), p.5997

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients

ERJ open research, 2023-05, Vol.9 (3), p.651

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(132)
Berichte
(2)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity

Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities

Oral anticoagulation is preferable to injected, but only if it is safe and effective: An interview study of patient and carer experience of oral and injected anticoagulant therapy for cancer-associated thrombosis in the select-d trial

Cancer patients’ experiences of the diagnosis and treatment of incidental pulmonary embolism (a qualitative study)

Deficient DNA mismatch repair and persistence of SARS-CoV-2 RNA shedding: a case report of hereditary nonpolyposis colorectal cancer with COVID-19 infection

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

Latest advances in preventing thromboembolic disease in the ambulatory oncology patient

Low molecular weight heparin and direct oral anticoagulants influence tumour formation, growth, invasion and vascularisation by separate mechanisms

Accumulation of tissue factor in endothelial cells promotes cellular apoptosis through over-activation of Src1 and involves β1-integrin signalling

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity

The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients

Cancer patients’ experiences of living with venous thromboembolism: A systematic review and qualitative thematic synthesis

Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles

Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation

Chemoradiation in Pancreatic Adenocarcinoma: A Literature Review

De-Palmitoylation of Tissue Factor Regulates Its Activity, Phosphorylation and Cellular Functions

Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study

Factor VIIa Regulates the Level of Cell-Surface Tissue Factor through Separate but Cooperative Mechanisms

Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series

COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials

Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients

Suchergebnisse filtern